Skip to content

Geron GERN Interest coverage

Interest coverage at other companies

Incyte logo
IncyteINCY
689.3×+620×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-55,882.3×
Arcus Biosciences logo
Arcus BiosciencesRCUS
-39.8×-15.5×
Celcuity logo
CelcuityCELC
-9.3×-1.0×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-84.7×
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
-9.8×

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's interest coverage?
Geron (GERN) reported interest coverage of -1.6× in Q1 2026.
How has Geron's interest coverage changed year-over-year?
Geron's interest coverage increased by 71.6% year-over-year, from -5.8× to -1.6×.
What is the long-term trend for Geron's interest coverage?
Over 4 years (2021 to 2025), Geron's interest coverage has grown at a -48.8% compound annual growth rate (CAGR), from -30.5× to -2.1×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.